The Reverse Stock Split will take legal effect at 12:01 A.M. Eastern Time on February 26, 2025, and the Company's Common Stock will open for trading on the NYSE American on February 26, 2025, on a ...
Karyopharm (KPTI) will implement a 1-for-15 reverse stock split of the issued shares of the company’s common stock effective at 5:00 p.m.
In a challenging year for Aclarion, the medical technology company's stock has plummeted to a 52-week low, trading at $4.41. According to InvestingPro data, the company maintains a healthy liquidity ...
BROOMFIELD, Colo. - Aclarion, Inc. (NASDAQ:ACON, ACONW), a healthcare technology company, announced today it has received a Notice of Allowance from the U.S. Patent and Trademark Office for a patent ...
SHOEMAKERSVILLE, Pa., Feb. 10, 2025 (GLOBE NEWSWIRE) -- Hydrofarm Holdings Group, Inc. (Nasdaq: HYFM) ("Hydrofarm” or the "Company”) today announced that its Board of Directors has approved a 1-for-10 ...
The reverse stock split will become effective at 5:00 p.m. Eastern Time on February 7, 2025, with the company’s common stock expected to begin trading on a split-adjusted basis at the opening of ...
In a bid to maintain compliance with Nasdaq's listing standards, Aclarion executed a reverse stock split at a ratio of 1-for-335. This move resulted in the company's gross proceeds reaching ...
Aclarion secured $20 million in funding for its clinical trial of Nociscan. Nociscan is a diagnostic tool that aims to improve surgical outcomes for chronic low back pain patients. Get two weeks ...
The reverse stock splits will not result in a taxable transaction for holders of the Funds, however, the exchange of fractional shares for cash may cause some shareholders to realize gains or ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results